Skip to content

CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHATAVARI KSHEERAPAKA IN THE MANAGEMENT OF GARBHINI MUTRAKRICCHRA W.S.R TO UTI IN PREGNANCY

A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHATAVARI KSHEERAPAKA IN THE MANAGEMENT OF GARBHINI MUTRAKRICCHRA W.S.R TO UTI IN PREGNANCY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034258
Enrollment
30
Registered
2021-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: SHATAVARI KSHEERAPAKA: SHATAVARI KSHEERAPAKA 50ml BD Time of administration - After food for 15 days Control Intervention1: Trinapanchmoola ksheerapaka: Trinapanchmoola ksheerapaka 50ml

Sponsors

Sri Sri College of Ayurvedic Science and Research Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with primi and multi gravida aged 20-40 years. Subjects presenting with gestational age of all three trimesters. Subjects having classical signs and symptoms of Mutrakricchra. Subjects presenting with Investigation showing pus cells>5cell/HPF in urine.

Exclusion criteria

Exclusion criteria: Subjects associated with systemic disorders like Diabetes, Hypertension etc. Subjects suffering from sexually transmitted diseases. Subjects with Chronic Kidney Disorders. Subjects with Recurrent Urinary tract infection. Subjects with Asymptomatic bacteriuria. Subjects suffering from COVID-19.

Design outcomes

Primary

MeasureTime frame
SHATAVARI KSHEERAPAKA is effective in GARBHINI MUTRAKRICCHRA i.e. there will be reduction in burning sensation, frequency of micturition , pain during micturition of GARBHINI MUTRAKRICCHRA Timepoint: 1st , 7th and 15th day

Secondary

MeasureTime frame
Trinapanchmoola ksheerapaka was proved to be effective in GARBHINI MUTRAKRICCHRA which will be assessed by reduction in classical symptoms of GARBHINI MUTRAKRICCHRATimepoint: 1st , 7th and 15th day

Countries

India

Contacts

Public ContactDr Savita S Patil

Sri Sri College of Ayurvedic Science and Research

rampursspatil@gmail.com9742193553

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026